Everest Medicines (01952) H2 2024 Earnings Call March 26, 2025 10:59 AM ET Company Participants Leah Liu - VP of Corporate AffairsRogers Yongqing Luo - Member of Board of Directors & CEOIan Woo - Executive Director, President and CEOSandra Zeng - Chief Medical OfficerWei Jennifer Yang - Chief Scientific Officer Conference Call Participants Linhai Percy Zhao - Equity Research Analyst Operator Good morning or good evening. Welcome to Everest Medicines Full Year twenty twenty four Financial Results Conference ...